MyEG to be made distributor of Zhifei vaccine


MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

PETALING JAYA: My E.G. Services Bhd has entered into a memorandum of understanding (MoU) with Anhui Zhifei Longcom Biopharmaceutical Co Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.

MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MyEG Services , distributor , Zgifei , vaccine ,

Next In Business News

Ringgit likely to trade cautiously next week ahead of key US data
Watts from water
Singapore’s financial sector a big winner
Up in Arms - or up the value chain?
Asia bonds for diversification
Smart city can’t beat the traffic
Powering a new reinvestment cycle as demand surges
AI disruption fears rock markets
Private equity hits a sixer
Dubai luxe property keeps booming

Others Also Read